| Product Code: ETC416376 | Publication Date: Oct 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Nucleic acid testing is gaining prominence in the UAE healthcare sector, particularly in diagnostics and disease surveillance. This market is driven by the need for accurate and rapid testing methods, especially during the ongoing COVID-19 pandemic.
Nucleic acid testing is crucial in disease diagnosis, particularly in the context of viral infections. The UAE efforts to enhance its healthcare system, especially in response to the COVID-19 pandemic, have led to significant growth in this market. Investments in testing facilities and healthcare infrastructure have been key drivers.
The UAE nucleic acid testing market is experiencing challenges related to the rapid adoption of molecular diagnostics and the need for large-scale testing, especially during health crises like pandemics. Ensuring accessibility, accuracy, and affordability of testing services is paramount.
The nucleic acid testing market in the UAE has undergone a significant transformation due to the COVID-19 pandemic. As a cornerstone of diagnostic testing, this sector has faced both surges in demand and technological innovations in response to the virus`s impact on public health.
Leading diagnostic companies including Roche Diagnostics and Abbott Laboratories are significant contributors to the UAE nucleic acid testing market, providing advanced molecular diagnostic technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Nucleic Acid Testing Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Nucleic Acid Testing Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Nucleic Acid Testing Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United Arab Emirates (UAE) Nucleic Acid Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Nucleic Acid Testing Market Trends |
6 United Arab Emirates (UAE) Nucleic Acid Testing Market, By Types |
6.1 United Arab Emirates (UAE) Nucleic Acid Testing Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Nucleic Acid Test Kits, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Transcription-Mediated Amplification (TMA), 2021-2031F |
6.1.5 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021-2031F |
6.1.6 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Ligase Chain Reaction (LCR), 2021-2031F |
6.1.7 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021-2031F |
6.1.8 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Consumables, 2021-2031F |
6.2 United Arab Emirates (UAE) Nucleic Acid Testing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Infectious diseases, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Forensic Testing, 2021-2031F |
6.2.5 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Others, 2021-2031F |
6.3 United Arab Emirates (UAE) Nucleic Acid Testing Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Pathology laboratories, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.3.5 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenues & Volume, By Clinics, 2021-2031F |
7 United Arab Emirates (UAE) Nucleic Acid Testing Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Nucleic Acid Testing Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Imports from Major Countries |
8 United Arab Emirates (UAE) Nucleic Acid Testing Market Key Performance Indicators |
9 United Arab Emirates (UAE) Nucleic Acid Testing Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Nucleic Acid Testing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Nucleic Acid Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United Arab Emirates (UAE) Nucleic Acid Testing Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Nucleic Acid Testing Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Nucleic Acid Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here